ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,330, issued on July 29, was assigned to Philip Morris Products S.A. (Neuchatel, Switzerland).
"Double activation prevention" was invented by Olivier Blattler (Lamboing, Switzerland), Onur Dayioglu (Neuchatel, Switzerland), Dominique Paul Gabriel Stohr (Belfaux, Switzerland), Benjamin Crook (Bremgarten bei Bern, Switzerland), Peter Loser (Herrenschwanden, Switzerland) and Gregoire Meylan (Marly, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "A holder for an inhaler article that includes a sleeve positioned within a housing cavity, a piercing element, and a lockout mechanism. The sleeve comprises a sleeve cavity arranged to receive the inh...